Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) ...

Gastroparesis is a chronic disorder that affects a significant subset of the population. Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the ...

In addition to treating symptoms, prokinetic drugs could potentially improve glycemic control in diabetic gastroparesis by allowing a more predictable absorption of nutrients, matched to the ...

Gastroparesis is most commonly associated with diabetes, but is also seen as a complication of other diseases and is also a recognised side effect of GLP-1 agonists used to treat diabetes and for ...

Ozempic and similar weight loss drugs are currently at the center of multidistrict litigation over claims that the drugs ...

A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

While you may have never heard of it, gastroparesis is a chronic condition that affects the way food passes through the ...

Such knowledge may be used to to ... High Muscle Strength Linked to Lower Risk of Type 2 Diabetes Apr. 8, 2025 — Researchers conducted a large-scale epidemiological study to explore the ...

Diabetic patients have to take special care of their diet. A little carelessness regarding diet can be very harmful to health. Diabetic patients are forbidden to eat sweets so that the glucose ...

Doctors in the UAE are warning of a newly recognised, silent form of diabetes — this disease doesn't stem from obesity or high sugar levels. Different from both Type 1 and Type 2 diabetes ...

"GLP-1 medications are currently the most effective weight loss adjunct available if the patient does not meet the criteria ...

There are around four million people living with a diabetes diagnosis in the UK, while another 1.3 million are believed to be living with undiagnosed type 2 diabetes, according to Diabetes UK ...